Saluja Medical Associates is categorized under Internal Medicine Doctors in Baltimore, MD and active since 2007.
Saluja Medical Associates was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Darshan Saluja at the company’s single location by writing to 821 North Eutaw St # 301, Baltimore, Maryland MD 21201 or by phoning (410) 462-3727. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Saluja Medical Associates |
| Contact Person: | Darshan Saluja |
| Address: | 821 North Eutaw St # 301, Baltimore, Maryland 21201 |
| Phone Number: | (410) 462-3727 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Saluja Medical Associates was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Darshan Saluja for inquiries that concern Saluja Medical Associates by calling the company number (410) 462-3727, as your correspondence is most welcome. Additionally, the physical location of the single location of Saluja Medical Associates can be found at the coordinates 39.299148,-76.621343 as well as the street address 821 North Eutaw St # 301 in Baltimore, Maryland 21201.
For its online presence, you may visit Saluja Medical Associates’s website at and engage with its social media outlets through on Twitter and on Facebook.